An overview of IL-17 function and signaling

Cytokine

Volumn 43, Issue 3, 2008, Pages 402-407

  Gaffen, Sarah L ^a  

^a UNIVERSITY AT BUFFALO   (United States)

Author keywords

Cytokine; Gene regulation; IL 17; Receptor

Indexed keywords

INTERLEUKIN 17; INTERLEUKIN 17 RECEPTOR;

AUTOIMMUNITY; HUMAN; INNATE IMMUNITY; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN INDUCTION; PROTEIN STRUCTURE; REVIEW; SIGNAL TRANSDUCTION;

ANIMALS; AUTOIMMUNE DISEASES; CYTOKINES; HUMANS; IMMUNITY, INNATE; INTERLEUKIN-17; RECEPTORS, INTERLEUKIN-17; SIGNAL TRANSDUCTION; T-LYMPHOCYTES, HELPER-INDUCER;

EID: 51349111163     PISSN: 10434666     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cyto.2008.07.017     Document Type: Review

References (101)

1. Ozaki K., and Leonard W.J. Cytokine and cytokine receptor pleiotropy and redundancy. J Biol Chem 277 (2002) 29355-29358
2. Shen F., and Gaffen S.L. Structure-function relationships in the IL-17 receptor: implications for signal transduction and therapy. Cytokine 41 (2008) 92-104
3. Rouvier E., Luciani M.-F., Mattei M.-G., Denizot F., and Golstein P. CTLA-8, cloned from an activated T cell, bearing AU-rich messenger RNA instability sequences, and homologous to a Herpesvirus Saimiri gene. J Immunol 150 (1993) 5445-5456
4. Yao Z., Painter S.L., Fanslow W.C., Ulrich D., Macduff B.M., Spriggs M.K., et al. Cutting edge: human IL-17: a novel cytokine derived from T cells. J Immunol 155 (1995) 5483-5486
5. Yao Z., Fanslow W.C., Seldin M.F., Rousseau A.-M., Painter S.L., Comeau M.R., et al. Herpesvirus saimiri encodes a new cytokine, IL-17, which binds to a novel cytokine receptor. Immunity 3 (1995) 811-821
6. Yao Z., Spriggs M.K., Derry J.M.J., Strockbine L., Park L.S., VandenBos T., et al. Molecular characterization of the human interleukin-17 receptor. Cytokine 9 (1997) 794-800
7. Moseley T.A., Haudenschild D.R., Rose L., and Reddi A.H. Interleukin-17 family and IL-17 receptors. Cytokine Growth Factor Rev 14 (2003) 155-174
8. Aggarwal S., and Gurney A.L. IL-17: a prototype member of an emerging family. J Leukoc Biol 71 (2002) 1-8
9. Fossiez F., Djossou O., Chomarat P., Flores-Romo L., Ait-Yahia S., Maat C., et al. T cell interleukin-17 induces stromal cells to produce proinflammatory and hematopoietic cytokines. J Exp Med 183 (1996) 2593-2603
10. Chang S.H., and Dong C. A novel heterodimeric cytokine consisting of IL-17 and IL-17F regulates inflammatory responses. Cell Res 17 (2007) 435-440
11. + T cells. J Biol Chem 282 (2007) 13447-13455
12. Hymowitz S.G., Filvaroff E.H., Yin J.P., Lee J., Cai L., Risser P., et al. IL-17s adopt a cystine knot fold: structure and activity of a novel cytokine, IL-17F, and implications for receptor binding. EMBO J 20 (2001) 5332-5341
13. Kramer J., Yi L., Shen F., Maitra A., Jiao X., Jin T., et al. Cutting edge: evidence for ligand-independent multimerization of the IL-17 receptor. J Immunol 176 (2006) 711-715
14. Toy D., Kugler D., Wolfson M., Vanden Bos T., Gurgel J., Derry J., et al. Cutting edge: interleukin-17 signals through a heteromeric receptor complex. J Immunol 177 (2006) 36-39
15. Chan F.K. Three is better than one: pre-ligand receptor assembly in the regulation of TNF receptor signaling. Cytokine 37 (2007) 101-107
16. Latz E., Verma A., Visintin A., Gong M., Sirois C.M., Klein D.C., et al. Ligand-induced conformational changes allosterically activate Toll-like receptor 9. Nat Immunol 8 (2007) 772-779
17. Kramer J., Hanel W., Shen F., Isik N., Malone J., Maitra A., et al. Cutting edge: identification of the pre-ligand assembly domain (PLAD) and ligand binding site in the IL-17 receptor. J Immunol 179 (2007) 6379-6383
18. Kramer J., and Gaffen S. Interleukin-17: a new paradigm in inflammation, autoimmunity and therapy. J Periodontol 78 (2007) 1083-1093
19. Kuestner R., Taft D., Haran A., Brandt C., Brender T., Lum K., et al. Identification of the IL-17 receptor related molecule, IL-17RC, as the receptor for IL-17F. J Immunol 179 (2007) 5462-5473
20. Haudenschild D., Moseley T., Rose L., and Reddi A.H. Soluble and transmembrane isoforms of novel interleukin-17 receptor-like protein by RNA splicing and expression in prostate cancer. J Biol Chem 277 (2002) 4309-4316
21. Raffatellu M., Santos R.L., Verhoeven D.E., George M.D., Wilson R.P., Winter S.E., et al. Simian immunodeficiency virus-induced mucosal interleukin-17 deficiency promotes Salmonella dissemination from the gut. Nat Med 14 (2008) 421-428
22. Aujla S.J., Chan Y.R., Zheng M., Fei M., Askew D.J., Pociask D.A., et al. IL-22 mediates mucosal host defense against Gram-negative bacterial pneumonia. Nat Med 14 (2008) 275-281
23. Shen F., Ruddy M.J., Plamondon P., and Gaffen S.L. Cytokines link osteoblasts and inflammation: microarray analysis of interleukin-17- and TNF-α-induced genes in bone cells. J Leukoc Biol 77 (2005) 388-399
24. Schwarzenberger P., La Russa V., Miller A., Ye P., Huang W., Zieske A., et al. IL-17 stimulates granulopoiesis in mice: Use of an alternate, novel gene therapy-derived method for in vivo evaluation of cytokines. J Immunol 161 (1998) 6383-6389
25. Kolls J.K., and Linden A. Interleukin-17 family members and inflammation. Immunity 21 (2004) 467-476
26. Linden A., Laan M., and Anderson G. Neutrophils, interleukin-17A and lung disease. Eur Respir J 25 (2005) 159-172
27. Ye P., Rodriguez F.H., Kanaly S., Stocking K.L., Schurr J., Schwarzenberger P., et al. Requirement of interleukin 17 receptor signaling for lung CXC chemokine and granulocyte colony-stimulating factor expression, neutrophil recruitment, and host defense. J Exp Med 194 (2001) 519-527
28. Kelly M.N., Kolls J.K., Happel K., Schwartzman J.D., Schwarzenberger P., Combe C., et al. Interleukin-17/interleukin-17 receptor-mediated signaling is important for generation of an optimal polymorphonuclear response against Toxoplasma gondii infection. Infect Immun 73 (2005) 617-621
29. Huang W., Na L., Fidel P.L., and Schwarzenberger P. Requirement of interleukin-17A for systemic anti-Candida albicans host defense in mice. J Infect Dis 190 (2004) 624-631
30. Yu J., Ruddy M., Wong G., Sfintescu C., Baker P., Smith J., et al. An essential role for IL-17 in preventing pathogen-initiated bone destruction: recruitment of neutrophils to inflamed bone requires IL-17 receptor-dependent signals. Blood 109 (2007) 3794-3802
31. Nakae S., Komiyama Y., Nambu A., Sudo K., Iwase M., Homma I., et al. Antigen-specific T cell sensitization is impaired in IL-17-deficient mice, causing suppression of allergic cellular and humoral responses. Immunity 17 (2002) 375-387
32. Yu J., and Gaffen S.L. Interleukin-17: a novel inflammatory cytokine that bridges innate and adaptive immunity. Front Biosci 13 (2008) 170-177
33. Witowski J., Pawlaczyk K., Breborowicz A., Scheuren A., Kuzlan-Pawlaczyk M., Wisniewska J., et al. IL-17 stimulates intraperitoneal neutrophil infiltration through the release of GRO alpha chemokine from mesothelial cells. J Immunol 165 (2000) 5814-5821
34. Ruddy M.J., Shen F., Smith J., Sharma A., and Gaffen S.L. Interleukin-17 regulates expression of the CXC chemokine LIX/CXCL5 in osteoblasts: implications for inflammation and neutrophil recruitment. J Leukoc Biol 76 (2004) 135-144
35. Yu J, Ruddy M, Conti H, Boonanantanasarn K, Gaffen SL. The IL-17 receptor plays a gender-dependent role in host protection against P. gingivalis-induced periodontal bone loss. Infect Immun in press.
36. Shen F., Hu Z., Goswami J., and Gaffen S.L. Identification of common transcriptional regulatory elements in interleukin-17 target genes. J Biol Chem 281 (2006) 24138-24148
37. Flo T.H., Smith K.D., Sato S., Rodriguez D.J., Holmes M.A., Strong R.K., et al. Lipocalin 2 mediates an innate immune response to bacterial infection by sequestrating iron. Nature 432 (2004) 917-921
38. Kao C.Y., Chen Y., Thai P., Wachi S., Huang F., Kim C., et al. IL-17 markedly up-regulates beta-defensin-2 expression in human airway epithelium via JAK and NF-kappaB signaling pathways. J Immunol 173 (2004) 3482-3491
39. Zheng Y., Danilenko D.M., Valdez P., Kasman I., Eastham-Anderson J., Wu J., et al. Interleukin-22, a T(H)17 cytokine, mediates IL-23-induced dermal inflammation and acanthosis. Nature 445 (2007) 648-651
40. Liang S.C., Tan X.Y., Luxenberg D.P., Karim R., Dunussi-Joannopoulos K., Collins M., et al. Interleukin (IL)-22 and IL-17 are coexpressed by Th17 cells and cooperatively enhance expression of antimicrobial peptides. J Exp Med 203 (2006) 2271-2279
41. Chen Y., Thai P., Zua Y.-H., Ho Y.-S., DeSouza M., and Wu R. Stimulation of airway mucin gene expression by interleukin (IL)-17 through IL-6 paracrine/autocrine loop. J Biol Chem 278 (2003) 17036-17043
42. Ganz T. Defensins and host defense. Science 286 (1999) 420-421
43. Oppenheim J.J., Biragyn A., Kwak L.W., and Yang D. Roles of antimicrobial peptides such as defensins in innate and adaptive immunity. Ann Rheum Dis 62 Suppl. 2 (2003) ii17-ii21
44. Yang D., Chertov O., Bykovskaia S.N., Chen Q., Buffo M.J., Shogan J., et al. β-Defensins: linking innate immunity and adaptive immunity through dendritic and T cell CCR6. Science 286 (1999) 525-528
45. Kao C.-Y., Huang F., Chen Y., Thai P., Wachi S., Kim C., et al. Up-regulation of CC chemokine ligand 20 expression in human airway epithelium by IL-17 through a JAK-independent but MEK-NF-kappaB-dependent signaling pathway. J Immunol 175 (2005) 6676-6685
46. + CXC chemokine expression in synoviocytes and are overexpressed in rheumatoid blood. J Immunol 180 (2008) 655-663
47. Wilson N.J., Boniface K., Chan J.R., McKenzie B.S., Blumenschein W.M., Mattson J.D., et al. Development, cytokine profile and function of human interleukin 17-producing helper T cells. Nat Immunol 8 (2007) 950-957
48. Hirota K., Yoshitomi H., Hashimoto M., Maeda S., Teradaira S., Sugimoto N., et al. Preferential recruitment of CCR6-expressing Th17 cells to inflamed joints via CCL20 in rheumatoid arthritis and its animal model. J Exp Med 204 (2007) 2803-2812
49. Yang D., Chen Q., Hoover D., Staley P., Tucker K., Lubkowski J., et al. Many chemokines including CCL20/MIP-3alpha display antimicrobial activity. J Leukoc Biol 74 (2003) 448-455
50. Rutitzky L.I., Lopes da Rosa J.R., and Stadecker M.J. Severe CD4 T cell-mediated immunopathology in murine schistosomiasis is dependent on IL-12p40 and correlates with high levels of IL-17. J Immunol 175 (2005) 3920-3926
51. Zelante T., De Luca A., Bonifazi P., Montagnoli C., Bozza S., Moretti S., et al. IL-23 and the Th17 pathway promote inflammation and impair antifungal immune resistance. Eur J Immunol 37 (2007) 2695-2706
52. Ghilardi N., and Ouyang W. Targeting the development and effector functions of Th17 cells. Semin Immunol 19 (2007) 383-393
53. Steinman L. A brief history of T(H)17, the first major revision in the T(H)1/T(H)2 hypothesis of T cell-mediated tissue damage. Nat Med 13 (2007) 139-1345
54. Lubberts E. IL-17/Th17 targeting: on the road to prevent chronic destructive arthritis?. Cytokine 41 (2008) 84-91
55. Lubberts E., Koenders M.I., Oppers-Walgreen B., van den Bersselaar L., Coenen-de Roo C.J., Joosten L.A., et al. Treatment with a neutralizing anti-murine interleukin-17 antibody after the onset of collagen-induced arthritis reduces joint inflammation, cartilage destruction, and bone erosion. Arthritis Rheum 50 (2004) 650-659
56. Nurieva R.I., Treuting P., Duong J., Flavell R.A., and Dong C. Inducible costimulator is essential for collagen-induced arthritis. J Clin Invest 111 (2003) 701-706
57. Nakae S., Nambu A., Sudo K., and Iwakura Y. Suppression of immune induction of collagen-induced arthritis in IL-17-deficient mice. J Immunol 171 (2003) 6173-6177
58. Ruddy M.J., Wong G.C., Liu X.K., Yamamoto H., Kasayama S., Kirkwood K.L., et al. Functional cooperation between interleukin-17 and tumor necrosis factor-a is mediated by CCAAT/enhancer binding protein family members. J Biol Chem 279 (2004) 2559-2567
59. Chabaud M., Fossiez F., Taupin J.L., and Miossec P. Enhancing effect of IL-17 on IL-1-induced IL-6 and leukemia inhibitory factor production by rheumatoid arthritis synoviocytes and its regulation by Th2 cytokines. J Immunol 161 (1998) 409-414
60. Chabaud M., and Miossec P. The combination of tumor necrosis factor alpha blockade with interleukin-1 and interleukin-17 blockade is more effective for controlling synovial inflammation and bone resorption in an ex vivo model. Arthritis Rheum 44 (2001) 1293-1303
61. Miossec P. Interleukin-17 in rheumatoid arthritis: if T cells were to contribute to inflammation and destruction through synergy. Arthritis Rheum 48 (2003) 594-601
62. Kikly K., Liu L., Na S., and Sedgwick J.D. The IL-23/Th(17) axis: therapeutic targets for autoimmune inflammation. Curr Opin Immunol 18 (2006) 670-675
63. Schwandner R., Yamaguchi K., and Cao Z. Requirement of tumor necrosis factor-associated factor (TRAF)6 in interleukin 17 signal transduction. J Exp Med 191 (2000) 1233-1239
64. Novatchkova M., Leibbrandt A., Werzowa J., Neubuser A., and Eisenhaber F. The STIR-domain superfamily in signal transduction, development and immunity. Trends Biochem Sci 28 (2003) 226-229
65. Kawai T., and Akira S. TLR signaling. Semin Immunol 19 (2007) 24-32
66. Li X. Act1 modulates autoimmunity through its dual functions in CD40L/BAFF and IL-17 signaling. Cytokine 41 (2008) 105-113
67. Maitra A., Shen F., Hanel W., Mossman K., Tocker J., Swart D., et al. Distinct functional motifs within the IL-17 receptor regulate signal transduction and target gene expression. Proc Natl Acad Sci USA 104 (2007) 7506-7511
68. Qian Y., Liu C., Hartupee J., Altuntas C.Z., Gulen M.F., Jane-Wit D., et al. The adaptor Act1 is required for interleukin 17-dependent signaling associated with autoimmune and inflammatory disease. Nat Immunol 8 (2007) 247-256
69. Chang S.H., Park H., and Dong C. Act1 adaptor protein is an immediate and essential signaling component of interleukin-17 receptor. J Biol Chem 281 (2006) 35603-35607
70. Hartupee J., Liu C., Novotny M., Li X., and Hamilton T. IL-17 enhances chemokine gene expression through mRNA stabilization. J Immunol 179 (2007) 4135-4141
71. Mosmann T.R., Cherwinski H., Bond M.W., Giedlin M.A., and Coffman R.L. Two types of murine helper T cell clone. I. Definition according to profiles of lymphokine activities and secreted proteins. J Immunol 136 (1986) 2348-2357
72. Infante-Duarte C., Horton H.F., Byrne M.C., and Kamradt T. Microbial lipopeptides induce the production of IL-17 in Th cells. J Immunol 165 (2000) 6107-6115
73. McGeachy M.J., and Cua D.J. Th17 cell differentiation: the long and winding road. Immunity 28 (2008) 445-453
74. McGeachy M.J., Bak-Jensen K.S., Chen Y., Tato C.M., Blumenschein W., McClanahan T., et al. TGF-beta and IL-6 drive the production of IL-17 and IL-10 by T cells and restrain T(H)-17 cell-mediated pathology. Nat Immunol 8 (2007) 1390-1397
75. Langrish C.L., Chen Y., Blumenschein W.M., Mattson J., Basham B., Sedgwick J.D., et al. IL-23 drives a pathogenic T cell population that induces autoimmune inflammation. J Exp Med 201 (2005) 233-240
76. Langrish C.L., McKenzie B.S., Wilson N.J., de Waal Malefyt R., Kastelein R.A., and Cua D.J. IL-12 and IL-23: master regulators of innate and adaptive immunity. Immunol Rev 202 (2004) 96-105
77. Duerr R.H., Taylor K.D., Brant S.R., Rioux J.D., Silverberg M.S., Daly M.J., et al. A Genome-Wide Association Study identifies IL23R as an inflammatory bowel disease gene. Science 314 (2006) 1461-1463
78. Acosta-Rodriguez E.V., Rivino L., Geginat J., Jarrossay D., Gattorno M., Lanzavecchia A., et al. Surface phenotype and antigenic specificity of human interleukin 17-producing T helper memory cells. Nat Immunol 8 (2007) 639-646
79. Korn T., Bettelli E., Gao W., Awasthi A., Jager A., Strom T.B., et al. IL-21 initiates an alternative pathway to induce proinflammatory T(H)17 cells. Nature 448 (2007) 484-487
80. Nurieva R., Yang X.O., Martinez G., Zhang Y., Panopoulos A.D., Ma L., et al. Essential autocrine regulation by IL-21 in the generation of inflammatory T cells. Nature 448 (2007) 480-483
81. Zhou L., Ivanov I.I., Spolski R., Min R., Shenderov K., Egawa T., et al. IL-6 programs T(H)-17 cell differentiation by promoting sequential engagement of the IL-21 and IL-23 pathways. Nat Immunol 8 (2007) 967-974
82. Stark M.A., Huo Y., Burcin T.L., Morris M.A., Olson T.S., and Ley K. Phagocytosis of apoptotic neutrophils regulates granulopoiesis via IL-23 and IL-17. Immunity 22 (2005) 285-294
83. Liu X.K., Clements J.L., and Gaffen S.L. Signaling through the murine T cell receptor induces IL-17 production in the absence of costimulation, IL-23 or dendritic cells. Mol Cells 20 (2005) 329-337
84. Rachitskaya A.V., Hansen A.M., Horai R., Li Z., Villasmil R., Luger D., et al. Cutting edge: NKT cells constitutively express IL-23 receptor and ROR{gamma}t and rapidly produce IL-17 upon receptor ligation in an IL-6-independent fashion. J Immunol 180 (2008) 5167-5171
85. Khader S.A., and Cooper A.M. IL-23 and IL-17 in tuberculosis. Cytokine 41 (2008) 79-83
86. Kohyama S., Ohno S., Isoda A., Moriya O., Belladonna M.L., Hayashi H., et al. IL-23 enhances host defense against vaccinia virus infection via a mechanism partly involving IL-17. J Immunol 179 (2007) 3917-3925
87. Khader S.A., Bell G.K., Pearl J.E., Fountain J.J., Rangel-Moreno J., Cilley G.E., et al. IL-23 and IL-17 in the establishment of protective pulmonary CD4(+) T cell responses after vaccination and during Mycobacterium tuberculosis challenge. Nat Immunol 8 (2007) 369-377
88. + effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages. Nat Immunol 6 (2005) 1123-1132
89. Park H., Li Z., Yang X.O., Chang S.H., Nurieva R., Wang Y.H., et al. A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17. Nat Immunol 6 (2005) 1133-1141
90. Stumhofer J.S., Laurence A., Wilson E.H., Huang E., Tato C.M., Johnson L.M., et al. Interleukin 27 negatively regulates the development of interleukin 17-producing T helper cells during chronic inflammation of the central nervous system. Nat Immunol 7 (2006) 937-945
91. Laan M., Cui A.-H., Hoshino H., Lötvall J., Sjöstrand M., Gruenert D.C., et al. Neutrophil recruitment by human IL-17 via C-X-C chemokine release in the airways. J Immunol 162 (1999) 2347-2352
92. Van Kooten C., Boonstra J.G., Paape M.E., Fossiez F., Banchereau J., Lebecque S., et al. Interleukin-17 activates human renal epithelial cells in vitro and is expressed during renal allograft rejection. J Am Soc Nephrol 9 (1998) 1526-1534
93. Andoh A., Yasui H., Inatomi O., Zhang Z., Deguchi Y., Hata K., et al. Interleukin-17 augments tumor necrosis factor-alpha-induced granulocyte and granulocyte/macrophage colony-stimulating factor release from human colonic myofibroblasts. J Gastroenterol 40 (2005) 802-810
94. Laan M., Prause O., Miyamoto M., Sjostrand M., Hytonen A.M., Kaneko T., et al. A role of GM-CSF in the accumulation of neutrophils in the airways caused by IL-17 and TNF-α. Eur Respir J 21 (2003) 387-393
95. He R., Shepard L.W., Chen J., Pan Z.K., and Ye R.D. Serum amyloid A is an endogenous ligand that differentially induces IL-12 and IL-23. J Immunol 177 (2006) 4072-4079
96. Patel D.N., King C.A., Bailey S.R., Holt J.W., Venkatachalam K., Agrawal A., et al. Interleukin-17 stimulates C-reactive protein expression in hepatocytes and smooth muscle cells via p38 MAPK and ERK1/2-dependent NF-kappaB and C/EBPbeta activation. J Biol Chem 282 (2007) 27229-27238
97. Chabaud M., Garnero P., Dayer J.M., Guerne P.A., Fossiez F., and Miossec P. Contribution of interleukin 17 to synovium matrix destruction in rheumatoid arthritis. Cytokine 12 (2000) 1092-1099
98. Bamba S., Andoh A., Yasui H., Araki Y., Bamba T., and Fujiyama Y. Matrix metalloproteinase-3 secretion from human colonic subepithelial myofibroblasts: role of interleukin-17. J Gastroenterol 38 (2003) 548-554
99. Jovanovic D.V., Martel-Pelletier J., Di Battista J.A., Mineau F., Jolicoeur F.-C., Benderdour M., et al. Stimulation of 92-kd gelatinase (matrix metalloproteinase 9) production by interleukin-17 in human monocyte/macrophages. Arthritis Rheum 43 (2000) 1134-1144
100. Rifas L., and Arackal S. T cells regulate the expression of matrix metalloproteinase in human osteoblasts via a dual mitogen-activated protein kinase mechanism. Arthritis Rheum 48 (2003) 993-1001
101. Yamazaki S., Muta T., Matsuo S., and Takeshige K. Stimulus-specific induction of a novel nuclear factor-kappaB regulator, IκB-zeta, via Toll/Interleukin-1 receptor is mediated by mRNA stabilization. J Biol Chem 280 (2005) 1678-1687